Fundraising FoxInmedix
Normandy Park, US · Delaware corporation · 1 known investors
Find your way into Inmedix
Each arrow is one introduction. Sign up to fill in the first one.
270 people can intro you to Andrew
Ask Stuart Hwang to introduce you to Andrew J Holman MD
You →Stuart · together at Inmedix Inc →Andrew
Sign up to find every way you can get introduced to Inmedix
- Your email: who you already know at Inmedix, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Inmedix team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Inmedix develops the CloudHRV System, an FDA-cleared clinical diagnostic that performs a 5-minute heart rate variability analysis of both the sympathetic and parasympathetic branches of the autonomic nervous system. The medical-grade test is used in clinical settings and covered by most insurance, with sites operating in Washington, Oregon, Michigan and Florida.
Founders & leadership
AJ
Andrew J Holman MDFounderAndrew J. Holman holds an MD and serves as CEO and co-founder of Inmedix, a company developing ECG-based heart rate variability technology for clinical applications. He is a clinical professor of medicine at the University of Washington with a background in clinical research on fibromyalgia and Parkinson's disease treatments, and leads efforts to bring point-of-care HRV assessment through FDA clearance.
AJ
Andrew J. HolmanMD
AH
Andrew Holman, M.D.Named on SEC filing
Board
BT
Bernie TobinBoard director
KT
Kevin Tracey, M.D.Board director
SD
Steven Daly, M.S., M.B.A.Board director
RS
Ryan Sullivan, Ph.D.Board director
LH
Leroy Hood, M.D., Ph.D.Board director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 5 rounds · 2021–2025
▶$160KraisedOct 2025 · 4 investors · BiotechnologyRule 506(c)
▶$160KraisedOct 2025 · 4 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bernie TobinDirector
- Andrew Holman, M.D.Executive Officer, Director
- Steven Daly, M.S., M.B.A.Director
- Leroy Hood, M.D., Ph.D.Director
- Kevin Tracey, M.D.Director
- Ryan Sullivan, Ph.D.Director
- Offering amount
- $5M
- Amount sold
- $160K
- Minimum investment
- $50K
- Proceeds to insiders
- $120K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$720KraisedNov 2024 · 5 investors · BiotechnologyRule 506(c)
▶$720KraisedNov 2024 · 5 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Bernie TobinDirector
- Kevin Tracey, M.D.Director
- Steven Daly, M.S., M.B.A.Director
- Ryan Sullivan, Ph.D.Director
- Leroy Hood, M.D., Ph.D.Director
- Andrew Holman, M.D.Executive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $720K
- Minimum investment
- $20K
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$25KraisedApr 2023 · BiotechnologyRule 506(c)
▶$25KraisedApr 2023 · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Leroy Hood, M.D., Ph.D.Director
- Kevin Tracey, M.D.Director
- Steven Daly, M.S., M.B.A.Director
- Andrew Holman, M.D.Executive Officer, Director
- Bernie TobinDirector
- Offering amount
- $3M
- Amount sold
- $25K
- Minimum investment
- $25K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$445KraisedMar 2022 · 6 investors · Other Health CareRule 506(b)
▶$445KraisedMar 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven J. DalyDirector
- Andrew J HolmanExecutive Officer, Director
- Bernie TobinDirector
- Offering amount
- $3M
- Amount sold
- $445K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$470KraisedMar 2021 · 8 investors · Other Health CareRule 506(b)
▶$470KraisedMar 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven DalyDirector
- Bernie TobinDirector
- Andrew J. HolmanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $470K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
TrimedxTrimedx is a clinical asset performance company that manages medical devices across health systems using on-site technicians, proprietary datasets, and AI-driven intelligence to optimize device reliability, reduce costs, and enhance security. It serves integrated delivery networks, regional and academic health systems, and community healthcare providers.
AugmedixAugmedix builds AI-driven documentation technology for clinicians, aiming to reduce time spent on technology so providers can focus on patient care. It serves healthcare organizations and their clinical staff.
InfraReDxInfraredx develops intravascular imaging technology that combines high-resolution structural imaging with plaque compositional analysis to inform vascular treatment decisions. The company operates in the medical device sector and is a U.S. subsidiary within Nipro Corporation's Vascular Division.
ImvaxImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Companies working in the same space as Inmedix.
Frequently asked questions
- What does Inmedix do?
- Inmedix develops the CloudHRV System, an FDA-cleared clinical diagnostic that performs a 5-minute heart rate variability analysis of both the sympathetic and parasympathetic branches of the autonomic nervous system. The medical-grade test is used in clinical settings and covered by most insurance, with sites operating in Washington, Oregon, Michigan and Florida.
- Who founded Inmedix?
- Inmedix was founded by Andrew J Holman MD, Andrew J. Holman.
- Who are Inmedix's investors?
- Inmedix's investors include Keiretsu Forum.
- How much funding has Inmedix raised?
- Inmedix has disclosed $1.8M raised across 5 rounds.
- Where is Inmedix headquartered?
- Inmedix is headquartered in Normandy Park, US.